Multidrug Resistant Pseudomonas aeruginosa from Wound & Pyogenic Infections.
MDR Pseudo. aeruginosa From Wound & Pyogenic Infections.
DOI:
https://doi.org/10.70284/njirm.v6i2.872Keywords:
Multidrug resistance, Pseudomonas aeruginosa, Wound & pyogenic infectionsAbstract
Background: Wound infections are one of the most common hospital acquired infections and are an important cause of morbidity and account for 70-80% mortality. Pseudomonas aeruginosa is an epitome of opportunistic nosocomial pathogen & responsible for serious infection such as septicemia ,pneumonia ,various pyogenic & wound infections. Pseudomonas aeruginosa is inherently resistant to many antibiotics and can mutate to even more resistant strains during therapy. So the present study aimed to find out the strains of Pseudomonas aeruginosa from various pyogenic & wound infections, their antibiotic sensitivity profile & to find out multidrug resistant strains. Methodology: Pseudomonas aeruginosa isolates obtained from pyogenic & wound infection samples were identified by conventional microbiological techniques. All these isolates were tested for antimicrobial susceptibility on Muller-Hinton’s agar by Kirby-Bauer disk diffusion method as per CLSI guidelines. Results: Out of 90 Pseudomonas aeruginosa strains,49 (54.44 %) were MDR strains & highest sensitivity was found to levofloxacin (74.44 %) ,amikacin, (67.77%),cefepime(65.55 %), pipercillin (64.4%) & ceftazidime (63.33 %). Conclusion: The prevalence of MDR strains in our study is 54.4 % which calls for the judicious selection of antibiotics in clinical practice. In addition, regular antimicrobial susceptibility surveillance is essential for area-wise monitoring of the resistance patterns. An effective national and state level antibiotic policy and draft guidelines should be introduced to preserve the effectiveness of antibiotics and for better patient management. [Chate S NJIRM 2015; 6(2):6-9]
References
2. Nutanbala N. Goswami, Hiren R.Trivedi. Antibiotic sensitivity profile of bacterial pathogens in postoperative wound infections at a tertiary care hospital in Gujarat, India.Journal of Pharmacology and Pharmacotherapeutics , July-September 2011;2(3):159
3. R. Amutha, Padmakrishnan,T. Murugan and M.P. Renugadevi .Studies on multidrug resistant Pseudomonas aeruginosa from pediatric population with special reference to extended spectrum beta lactamase.Indian Journal of Science and Technology,Nov.2009 ;2(11) ISSN: 0974- 6846
4. Raja NS,Singh NN.Antimicrobial susceptibility pattern of clinical isolates of Pseudomonas aeruginosa in a tertiary care hospital. J Microbiol Immunol Infect. Feb 2007;40(1):45-9.
5. A.Manoharan ,S.Chatterjee, D. Mathai, SARI Study Group . Detection and characterization of metallo-betalactamases producing Pseudomonas aeruginosa.IJMM2010;28(3):241-244
6. Mulugeta K. Azene and Bayeh A. Beyene. Bacteriology and antibiogram of pathogens from wound infections at DessieLaboratory, North East Ethiopia.Tanzania Journal of Health Research, October 2011; 13(4):1-10
7. Chickmagalure Shivaswamy VinodKumar & SrinivasaHiresave & Basavarajappa KandagalGiriyapal & Nitin Bandekar.Metallo Beta Lactamase Producing Pseudomonas aeruginosa and its association with diabetic foot. Indian J Surg ,July–August 2011;73(4):291–294
8. Identification of bacteria. In: Mackie and Mc Cartney Practical Medical Microbiology.Collee JG,Fraser AG, Marmion BP & Simmons A.4th ed.Edinburg:Churchill Livingstone.p:131-50.
9. Collee J et al Mackie and McCartney’s Practical Medical Microbiology 2006;14th edition: 131-145
10. Wayne P(2004). Performance standards for antimicrobial susceptibility testing .Twelfth informational supplement .National Committee for Clinical Laboratory standards.(NCCLS).M2A7 ;22(1).
11. Mehta M, Punia JN and Joshi RM. Antibiotic resistance in Pseudomonas aeruginosa strains isolated from various clinical specimen- a retrospective study. Indian J. Med. Microbiol 2001 ;19(4):232.
12. Hemalatha V, Sekar U, Kamat V. Detection of metallo- β-lactamase producing Pseudomonas aeruginosa in hospitalized patients.Indian J Med Res,2005;122:148-52
13. S. Murugan et al ,R.Bekkiya Lakshmi, P. Uma Devi , K.R. Mani. Prevalence & Antibiotic susceptibility pattern in metallo- β-lactamase producing Pseudomonas aeruginosa in diabetic foot infection. International Journal of Microbiological research 2010;1(3):123-128
14. Moniri R, Mosayebi Z, Movahedian AH, Mousavi GA. Emergence of multidrug resistant
Pseudomonas aeruginosa isolates in neonatal septicemia. J Infect Dis Antimicrob Agents. 2005;22:39–44.
15. Navaneeth BV, Sridaran D, Sahay D and Belwadi MR. A preliminary study on metallo –beta-lactamase producing Pseudomonas aeruginosa in hospitalized patients. Indian J. Med. Res. 2002;116:264-267.
16. Agnihotri N, Gupta V and Joshi RM. Aerobic bacterial isolates from burn wound infections and their antibiogram-a five year study. Burns 2004;30:241-243.
17. Siva SubbaRao.Pakanati, Shaikkhaja Mohiddin .Pseudomonas aeruginosa in Chronic Supurative Otitis Media- sensitivity spectrum against various antibiotics in Karaikal. IJBAMR, September-2014;3(4):P-52-55.
